CAPITAL STOCK (Tables)

6 Months Ended

Jan. 31, 2017

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]

Schedule of Share Transactions [Table Text Block]

A summary of the Company’s share transactions for the six months ended January 31, 2017 are as follows:

	Common		Value per Share				Issuance
Period / Description	Shares Issued		Low		High		Value
Balance, July 31, 2016		116,670,457
Mineral Property		46,800	$	1.04	$	1.04	$	48,672
Consulting Services		166,926		0.90		1.06		175,908
Options Exercised ⁽¹⁾		133,125		0.45		0.45		59,906
Settlement of Current Liabilities		88,822		1.03		1.03		91,488
Shares Issued Under Stock Incentive Plan		292,957		0.93		1.09		291,770
Balance, October 31, 2016		117,399,087
Equity Financing		17,330,836		1.50		1.50		25,996,254
Consulting Services		156,666		0.86		1.35		177,366
Options Exercised ⁽²⁾		87,050		0.45		0.93		40,862
Warrants Exercised		1,179,493		1.20		1.20		1,415,392
Shares Issued Under Stock Incentive Plan		243,769		0.88		1.49		236,323
Balance, January 31, 2017		136,396,901

⁽¹⁾ 100,000 options were exercised on a forfeiture basis, of which 46,875 shares with a value of $21,094 were forfeited as payment for the exercise value resulting in 53,125 net shares being issued with a value of $23,906 as a consequence of such exercise.

⁽²⁾ 142,134 options were exercised on a forfeiture basis, of which 57,584 shares with a value of $26,624 were forfeited as payment for the exercise resulting in 84,550 net shares being issued with a value of $38,537 as a consequence of such exercise.

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of share purchase warrants outstanding and exercisable at January 31, 2017 are as follows:

Weighted						Weighted Average
Average		Number of Warrants				Remaining Contractual
Exercise Price		Outstanding			Expiry Date	Life (Years)
$	1.20		5,414,855		March 10, 2019		2.10
	1.35		2,600,000		January 30, 2020		3.00
	1.95		50,000		June 3, 2018		1.34
	2.00		9,571,934	*	January 20, 2020		2.97
	2.35		2,850,000		June 25, 2018		1.40
$	1.75		20,486,789				2.52

^{*These share purchase warrants will be exercisable on July 20, 2017 pursuant to the Equity Financing.}

Schedule of Share based Compensation Arrangement by Share based Payment Award Options Grants in Period Activity [Table Text Block]

A summary of stock options granted by the Company during the six months ended January 31, 2017, including corresponding grant date fair values and assumptions using the Black Scholes option pricing model is as follows:

	Options		Exercise		Term		Fair		Expected		Risk-Free			Dividend			Expected
Date	Issued		Price		(Years)		Value		Life (Years)		Interest Rate			Yield			Volatility
August 2, 2016		182,500	$	0.93		5.00	$	90,222		2.90		0.78	%		0.00	%		84.14	%
August 12, 2016		190,000		1.12		5.00		106,339		2.90		0.81	%		0.00	%		78.07	%
December 9, 2016		50,000		1.07		5.00		25,999		2.50		1.29	%		0.00	%		80.90	%
December 9, 2016		100,000		1.07		5.00		53,819		2.90		1.40	%		0.00	%		77.87	%
Total		522,500					$	276,379

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A continuity schedule of outstanding stock options for the underlying common shares for the six months ended January 31, 2017 is as follows:

					Weighted Average
	Number of Stock		Weighted Average		Remaining Contractual
	Options		Exercise Price		Term (Years)
Balance, July 31, 2016		12,105,858	$	1.34		3.36
Issued		372,500		1.03		4.77
Exercised		(180,000)		0.45		-
Expired		(10,724)		5.13		-
Balance, October 31, 2016		12,287,634	$	1.34		3.21
Issued		150,000		1.07		4.85
Exercised		(144,634)		0.47		-
Expired		(40,000)		2.46		-
Balance, January 31, 2017		12,253,000	$	1.35		3.02

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

A summary of stock options outstanding and exercisable at January 31, 2017 is as follows:

	Options Outstanding				Options Exercisable
	Outstanding at		Weighted Average		Exercisable at		Weighted Average
Range of Exercise Prices	January 31, 2017		Exercise Price		January 31, 2017		Exercise Price
$0.45 to $0.96		2,755,500	$	0.77		1,804,625	$	0.69
$0.97 to $2.45		8,662,500		1.34		8,095,000		1.36
$2.46 to $5.70		835,000		3.33		835,000		3.33
		12,253,000	$	1.35		10,734,625	$	1.40

Schedule Of Stock based Compensation Expense [Table Text Block]

A summary of stock-based compensation expense is as follows:

	Three Months Ended January 31,				Six Months Ended January 31,
	2017		2016		2017		2016
Stock-Based Compensation for Consultants
Common stock issued for consulting services	$	252,895	$	633,180	$	522,027	$	958,775
Stock options issued to consultants		199,979		62,143		278,251		70,778
		452,874		695,323		800,278		1,029,553
Stock-Based Compensation for Management
Common stock issued to management		54,693		20,932		142,893		36,196
Stock options issued to management		122,326		265,010		367,345		445,325
		177,019		285,942		510,238		481,521
Stock-Based Compensation for Employees
Common stock issued to employees		106,101		30,303		216,447		30,303
Stock options issued to employees		93,046		50,781		287,338		147,414
		199,147		81,084		503,785		177,717
	$	829,040	$	1,062,349	$	1,814,301	$	1,688,791

Warrant [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The share purchase warrants were valued using the Black-Scholes option pricing model with the following assumptions:

Expected Risk Free Interest Rate	1.50	%
Expected Annual Volatility	76.96	%
Expected Contractual Life in Years	3.00
Expected Annual Dividend Yield	0.00	%

Schedule of Stockholders Equity [Table Text Block]

The net proceeds from the Equity Financing were allocated to the fair values of the shares and share purchase warrants as presented below:

Fair Value of Shares	$	26,689,487
Fair Value of Share Purchase Warrants		5,873,932
Total Fair Value Before Allocation to Net Proceeds	$	32,563,419

Gross Proceeds	$	25,996,254
Share Issuance Costs - Cash		(1,550,843)
Net Cash Proceeds Received	$	24,445,411

Relative Fair Value Allocation to:
Shares	$	20,035,841
Share Purchase Warrants		4,409,570
	$	24,445,411

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A continuity schedule of outstanding share purchase warrants for the six months ended January 31, 2017 is as follows:

					Weighted Average
	Number of		Weighted Average		Remaining Contractual
	Warrants		Exercise Price		Term (Years)
Balance, July 31, 2016		13,953,872		1.65		2.31
Issued		9,571,934		2.00		2.97
Exercised		(1,179,493)		1.20		-
Expired		(1,859,524)		2.60		-
Balance, January 31, 2017		20,486,789	$	1.75		2.52